Official Journal of The Kidney Cancer Association
Volume 18, Number 1 2020
www.kidney-cancer-journal.com
Reinventing the Paradigm of
IL-2 Therapy: A Roundtable
Discussion Analyzes Potential
Impact
Targeting the VHL-HIF Pathway:
Strategies and Challenges
Is Circulating Tumor DNA Ready
for Prime Time?
An Edu cational Service for Medical Oncologists, Hematologist-Oncologists, and Urologists
Now in Its 18th Year
/www.kidney-cancer-journal.com